Blood thinner tested to unclog leg arteries
NCT ID NCT05009862
Summary
This study is testing if adding a low dose of the blood thinner rivaroxaban to standard aspirin therapy helps improve blood vessel health and reduce harmful blood clotting in people with peripheral artery disease (PAD). Researchers are enrolling 75 adults with PAD to see if the drug helps blood vessels relax better and makes platelets less 'sticky.' The goal is to understand how this medication might help manage the disease beyond just preventing clots.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.